AbbVie Long-Term Investments 2010-2024 | ABBV

AbbVie long-term investments for the quarter ending September 30, 2024 were $0.272B, a 5.56% decline year-over-year.

  • AbbVie long-term investments for 2023 were $0.304B, a 26.14% increase from 2022.
  • AbbVie long-term investments for 2022 were $0.241B, a 13% decline from 2021.
  • AbbVie long-term investments for 2021 were $0.277B, a 5.46% decline from 2020.

AbbVie Long-Term Investments 2010-2024 | ABBV

  • AbbVie long-term investments for 2023 were $0.304B, a 26.14% increase from 2022.
  • AbbVie long-term investments for 2022 were $0.241B, a 13% decline from 2021.
  • AbbVie long-term investments for 2021 were $0.277B, a 5.46% decline from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$789.4B
Novo Nordisk (NVO)$481.1B
Johnson & Johnson (JNJ)$374.3B
Merck (MRK)$260.4B
Novartis AG (NVS)$217.6B
AstraZeneca (AZN)$200B
Pfizer (PFE)$151.4B
Sanofi (SNY)$130.2B
Innoviva (INVA)$1.3B